Fletcher Allen Thrombosis and Hemostasis ProgramLaboratory for Clinical Biochemistry Research
Fletcher Allen Health Care Blog - Going Red for Women at Fletcher Allen Heath Care
1996 M.Sc., Epidemiology, Harvard University, School of Public Health, Boston, Massachusetts
1989 M.D., University of Vermont College of Medicine, Burlington, Vermont
1985 B.S. (cum laude), Biology, University of Vermont, Burlington, Vermont
1992-1995 Fellow in Hematology, Department of Medicine, University of Vermont and Fletcher Allen Health Care, Burlington, Vermont
1993-1995 Research Fellow in Hemostasis, Department of Pathology, University of Vermont, Burlington, Vermont
1989-1992 Resident in Internal Medicine, Traditional Track, Department of Medicine, Medical Center Hospital of Vermont, Burlington, Vermont
The care of patients with venous thrombosis and its complications, with an emphasis on tailoring treatments to an individual's level of risk, and on evaluations for inherited and acquired hypercoagulable syndromes when appropriate. Evaluation and management of patients with premature or unexplained arterial vascular disease and the role of novel risk factors in their management. Evaluation and management of antiphospholipid syndrome. Optimization of the quality of acute and chronic administration of anticoagulant medications for treatment and prevention of thrombosis.
The epidemiology of coagulation, inflammation, and other vascular-related domains in relation to etiology and pathogenesis of cardiovascular diseases (myocardial infarction, stroke, and venous thrombosis) and other diseases of aging. The role of disorders of coagulation in venous and arterial thrombotic disease, and the therapy of these disorders. Racial disparities, especially in stroke and venous disease. Etiologic factors in post-thrombotic syndrome and chronic venous disease.
2007 - Present Professor with Tenure, Departments of Medicine and Pathology, University of Vermont, Burlington, Vermont.
1995 - Present Attending Physician, Department of Medicine, Fletcher Allen Health Care, Burlington, Vermont.
2001 - 2007 Associate Professor with Tenure, Departments of Medicine and Pathology, University of Vermont, Burlington, Vermont.
1995 - 2001 Assistant Professor, Departments of Medicine and Pathology, University of Vermont, Burlington, Vermont.
1992 -1995 Clinical Instructor of Medicine, Department of Medicine, University of Vermont and Fletcher Allen Health Care, Burlington, Vermont
2013 Appointed to American Heart Association Board of Directors
2011 Crystal Heart Award. American Heart Association Vermont. For volunteer service.
2009 Special Session Speaker, American Heart Association Scientific Sessions 2009. CRP and Cardiovascular Risk: what is the State of the Evidence?
2009 Distinguished Academic Achievement Award. University of Vermont College of Medicine Alumni Association.
2007 Special Session Speaker, American Heart Association Scientific Sessions 2007. Is there a Clinical Role for Inflammatory Markers? Who to Treat and How?
2005 Plenary Speaker, American Heart Association, 78th Scientific Sessions. Challenges in Acute Coronary Syndromes: Assessing and Modifying Inflammation.
2001 Fellow of the American Heart Association (FAHA)
2001 Recent Alumni Award, University of Vermont College of Medicine. For service to the community or the institution and / or scientific accomplishment
2014 Howard G, Wagenknecht LE, Kernan WN, Cushman M, Thacker EL, Judd SE, Howard VJ, Kissela BM. Racial Differences in the Association of Insulin Resistance With Stroke Risk: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Stroke. 2014 Jun 26. [PubMed - as supplied by publisher]
2014 Kent ST, Cushman M, Howard G, Judd SE, Crosson WL, Al-Hamdan MZ, McClure LA. Sunlight exposure and cardiovascular risk factors in the REGARDS study: a cross-sectional split-sample analysis. BMC Neurol. 2014 Jun 19;14(1):133. [PubMed - in process]
2014 Thacker EL, Gillett SR, Wadley VG, Unverzagt FW, Judd SE, McClure LA, Howard VJ, Cushman M. The American Heart Association life's simple 7 and incident cognitive impairment: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc. 2014 Jun 11;3(3):e000635. [PubMed - in process]
2014 Cushman M, Callas P, Allison MA, Criqui MH. Inflammation and peripheral venous disease. The San Diego Population Study. Thromb Haemost. 2014 Jun 5;112(3). [PubMed - as supplied by publisher]
2014 Shea MK, Cushman M, Booth SL, Burke GL, Chen H, Kritchevsky SB. Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults. The Multi-Ethnic Study of Atherosclerosis. Thromb Haemost. 2014 May 22;112(3).[PubMed - as supplied by publisher]
2014 Cushman M, Judd SE, Howard VJ, Kissela B, Gutiérrez OM, Jenny NS, Ahmed A, Thacker EL, Zakai NA. N-Terminal Pro-B-type Natriuretic Peptide and Stroke Risk: The Reasons for Geographic and Racial Differences in Stroke Cohort. Stroke. 2014 Apr 22. [PubMed - as supplied by publisher]
2014 Muntner P, Colantonio LD, Cushman M, Goff DC Jr, Howard G, Howard VJ, Kissela B, Levitan EB, Lloyd-Jones DM, Safford MM. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. JAMA. 2014 Apr 9;311(14):1406-15. [PubMed - indexed for MEDLINE]
2014 Folsom AR, Lutsey PL, Nambi V, deFilippi CR, Heckbert SR, Cushman M, Ballantyne CM. Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Vasc Med. 2014 Feb;19(1):33-41. [PubMed - in process]
2014 Engbers MJ, Blom JW, Cushman M, Rosendaal FR, van Hylckama Vlieg A. The contribution of immobility risk factors to the incidence of venous thrombosis in an older population. J Thromb Haemost. 2014 Mar;12(3):290-6. [PubMed - in process]
For a complete list of Mary Cushman's publications, please visit Google Scholar